Literature DB >> 32440005

Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker.

Miquel Duran-Frigola1, Eduardo Pauls2, Oriol Guitart-Pla2, Martino Bertoni2, Víctor Alcalde2, David Amat2, Teresa Juan-Blanco2, Patrick Aloy3,4.   

Abstract

Small molecules are usually compared by their chemical structure, but there is no unified analytic framework for representing and comparing their biological activity. We present the Chemical Checker (CC), which provides processed, harmonized and integrated bioactivity data on ~800,000 small molecules. The CC divides data into five levels of increasing complexity, from the chemical properties of compounds to their clinical outcomes. In between, it includes targets, off-targets, networks and cell-level information, such as omics data, growth inhibition and morphology. Bioactivity data are expressed in a vector format, extending the concept of chemical similarity to similarity between bioactivity signatures. We show how CC signatures can aid drug discovery tasks, including target identification and library characterization. We also demonstrate the discovery of compounds that reverse and mimic biological signatures of disease models and genetic perturbations in cases that could not be addressed using chemical information alone. Overall, the CC signatures facilitate the conversion of bioactivity data to a format that is readily amenable to machine learning methods.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32440005     DOI: 10.1038/s41587-020-0502-7

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  75 in total

Review 1.  Natural Products as Sources of New Drugs from 1981 to 2014.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2016-02-07       Impact factor: 4.050

2.  Drug target identification using side-effect similarity.

Authors:  Monica Campillos; Michael Kuhn; Anne-Claude Gavin; Lars Juhl Jensen; Peer Bork
Journal:  Science       Date:  2008-07-11       Impact factor: 47.728

3.  Rethinking molecular similarity: comparing compounds on the basis of biological activity.

Authors:  Paula M Petrone; Benjamin Simms; Florian Nigsch; Eugen Lounkine; Peter Kutchukian; Allen Cornett; Zhan Deng; John W Davies; Jeremy L Jenkins; Meir Glick
Journal:  ACS Chem Biol       Date:  2012-05-31       Impact factor: 5.100

Review 4.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

Review 5.  Privileged scaffolds for library design and drug discovery.

Authors:  Matthew E Welsch; Scott A Snyder; Brent R Stockwell
Journal:  Curr Opin Chem Biol       Date:  2010-03-18       Impact factor: 8.822

6.  Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.

Authors:  Brinton Seashore-Ludlow; Matthew G Rees; Jaime H Cheah; Murat Cokol; Edmund V Price; Matthew E Coletti; Victor Jones; Nicole E Bodycombe; Christian K Soule; Joshua Gould; Benjamin Alexander; Ava Li; Philip Montgomery; Mathias J Wawer; Nurdan Kuru; Joanne D Kotz; C Suk-Yee Hon; Benito Munoz; Ted Liefeld; Vlado Dančík; Joshua A Bittker; Michelle Palmer; James E Bradner; Alykhan F Shamji; Paul A Clemons; Stuart L Schreiber
Journal:  Cancer Discov       Date:  2015-10-19       Impact factor: 39.397

7.  PubChem BioAssay: 2017 update.

Authors:  Yanli Wang; Stephen H Bryant; Tiejun Cheng; Jiyao Wang; Asta Gindulyte; Benjamin A Shoemaker; Paul A Thiessen; Siqian He; Jian Zhang
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

8.  The ChEMBL database in 2017.

Authors:  Anna Gaulton; Anne Hersey; Michał Nowotka; A Patrícia Bento; Jon Chambers; David Mendez; Prudence Mutowo; Francis Atkinson; Louisa J Bellis; Elena Cibrián-Uhalte; Mark Davies; Nathan Dedman; Anneli Karlsson; María Paula Magariños; John P Overington; George Papadatos; Ines Smit; Andrew R Leach
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

9.  Chapter 3: Small molecules and disease.

Authors:  David S Wishart
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

10.  The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins.

Authors:  Andrew D Rouillard; Gregory W Gundersen; Nicolas F Fernandez; Zichen Wang; Caroline D Monteiro; Michael G McDermott; Avi Ma'ayan
Journal:  Database (Oxford)       Date:  2016-07-03       Impact factor: 3.451

View more
  19 in total

Review 1.  Metabolomics and genomics in natural products research: complementary tools for targeting new chemical entities.

Authors:  Lindsay K Caesar; Rana Montaser; Nancy P Keller; Neil L Kelleher
Journal:  Nat Prod Rep       Date:  2021-11-17       Impact factor: 13.423

2.  Machine learning methods, databases and tools for drug combination prediction.

Authors:  Lianlian Wu; Yuqi Wen; Dongjin Leng; Qinglong Zhang; Chong Dai; Zhongming Wang; Ziqi Liu; Bowei Yan; Yixin Zhang; Jing Wang; Song He; Xiaochen Bo
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

Review 3.  Web resources facilitate drug discovery in treatment of COVID-19.

Authors:  Long-Can Mei; Yin Jin; Zheng Wang; Ge-Fei Hao; Guang-Fu Yang
Journal:  Drug Discov Today       Date:  2021-04-20       Impact factor: 7.851

Review 4.  From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.

Authors:  Quentin T L Pasquer; Ioannis A Tsakoumagkos; Sascha Hoogendoorn
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

Review 5.  Zoopharmacology: A Way to Discover New Cancer Treatments.

Authors:  Eva María Domínguez-Martín; Joana Tavares; Patrícia Rijo; Ana María Díaz-Lanza
Journal:  Biomolecules       Date:  2020-05-26

Review 6.  Incorporating Machine Learning into Established Bioinformatics Frameworks.

Authors:  Noam Auslander; Ayal B Gussow; Eugene V Koonin
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

7.  Bioactivity descriptors for uncharacterized chemical compounds.

Authors:  Martino Bertoni; Miquel Duran-Frigola; Pau Badia-I-Mompel; Eduardo Pauls; Modesto Orozco-Ruiz; Oriol Guitart-Pla; Víctor Alcalde; Víctor M Diaz; Antoni Berenguer-Llergo; Isabelle Brun-Heath; Núria Villegas; Antonio García de Herreros; Patrick Aloy
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

8.  GRAND: a database of gene regulatory network models across human conditions.

Authors:  Marouen Ben Guebila; Camila M Lopes-Ramos; Deborah Weighill; Abhijeet Rajendra Sonawane; Rebekka Burkholz; Behrouz Shamsaei; John Platig; Kimberly Glass; Marieke L Kuijjer; John Quackenbush
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

9.  The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.

Authors:  Maiia E Bragina; Antoine Daina; Marta A S Perez; Olivier Michielin; Vincent Zoete
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

10.  A community challenge for a pancancer drug mechanism of action inference from perturbational profile data.

Authors:  Eugene F Douglass; Robert J Allaway; Bence Szalai; Wenyu Wang; Tingzhong Tian; Adrià Fernández-Torras; Ron Realubit; Charles Karan; Shuyu Zheng; Alberto Pessia; Ziaurrehman Tanoli; Mohieddin Jafari; Fangping Wan; Shuya Li; Yuanpeng Xiong; Miquel Duran-Frigola; Martino Bertoni; Pau Badia-I-Mompel; Lídia Mateo; Oriol Guitart-Pla; Verena Chung; Jing Tang; Jianyang Zeng; Patrick Aloy; Julio Saez-Rodriguez; Justin Guinney; Daniela S Gerhard; Andrea Califano
Journal:  Cell Rep Med       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.